Effects of early captopril administration after thrombolysis on regional wall motion in relation to infarct artery blood flow
John K. French, MB, PhDa,
David J. Amos, MBa,
Barbara F. Williams, RNa,
David B. Cross, MBa,
John M. Elliott, MB, PhDa,
Hamish H. Hart, MBa,
Miles G. Williams, MBa,
Robin M. Norris, MDa,
Noel G. Ashton, BSc, LTha,
Ralph M. L. Whitlock, MBa,
Stephanie C. McLaughlin, PhDa and
Harvey D. White, MB, DSca
a Department of Cardiology, Green Lane Hospital, Auckland, New Zealand

View larger version (11K):
[in a new window]
|
Figure 2 Cardiac mortality according to treatment randomization. Log-rank comparisons of cardiac mortality in the captopril (243) and placebo (250) groups at 1, 3 and 5 years were p = 0.044, p = 0.045 and p = 0.063, respectively. At these follow-up times the number of patients were 435, 332 and 122, respectively.
|
|

View larger version (19K):
[in a new window]
|
Figure 3 Effect of captopril on regional wall motion in anterior infarction according to corrected TIMI frame counts. (A) Number of abnormal chords; (B) number of chords >2 SD below normal; (C) total hypokinetic chords. Only the comparisons indicated were significant.
|
|
|